STOCK TITAN

[144] Zai Lab Limited American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Zai Lab Director and Officer Ying Du filed Form 144 indicating a proposed sale of 23,669 American Depositary Shares with an aggregate market value of $855,196.47 through Fidelity Brokerage Services. The shares were acquired through restricted stock vesting on June 25, 2025, as part of compensation.

Notable recent trading activity by Du includes:

  • Multiple large sales in May 2025 totaling 196,389 shares with combined proceeds of $5.68 million
  • Two smaller sales in April 2025 totaling 8,753 shares for $305,978

The filing indicates the sale is partially intended to cover tax obligations from vested equity awards. Du has certified no knowledge of undisclosed material adverse information regarding Zai Lab's operations. The company has 486.85 million shares outstanding, and the proposed sale represents approximately 0.005% of total shares.

Ying Du, Direttore e Dirigente di Zai Lab, ha presentato il Modulo 144 indicando la proposta vendita di 23.669 American Depositary Shares per un valore di mercato complessivo di 855.196,47 $ tramite Fidelity Brokerage Services. Le azioni sono state acquisite tramite il vesting di azioni vincolate il 25 giugno 2025, come parte della retribuzione.

Tra le attività di trading recenti più rilevanti di Du si segnalano:

  • Numerose vendite importanti a maggio 2025 per un totale di 196.389 azioni con proventi complessivi di 5,68 milioni di $
  • Due vendite minori ad aprile 2025 per un totale di 8.753 azioni per 305.978 $

La dichiarazione indica che la vendita è in parte destinata a coprire obblighi fiscali derivanti da premi azionari maturati. Du ha certificato di non avere conoscenza di informazioni materiali negative non divulgate riguardanti le operazioni di Zai Lab. La società ha 486,85 milioni di azioni in circolazione e la vendita proposta rappresenta circa lo 0,005% del totale azionario.

Ying Du, Director y Oficial de Zai Lab, presentó el Formulario 144 indicando una propuesta de venta de 23,669 American Depositary Shares con un valor de mercado agregado de $855,196.47 a través de Fidelity Brokerage Services. Las acciones fueron adquiridas mediante la consolidación de acciones restringidas el 25 de junio de 2025, como parte de su compensación.

Las actividades comerciales recientes destacadas de Du incluyen:

  • Múltiples ventas grandes en mayo de 2025 que totalizan 196,389 acciones con ingresos combinados de $5.68 millones
  • Dos ventas menores en abril de 2025 que suman 8,753 acciones por $305,978

La presentación indica que la venta es parcialmente para cubrir obligaciones fiscales derivadas de premios de acciones consolidadas. Du ha certificado que no tiene conocimiento de información adversa material no divulgada sobre las operaciones de Zai Lab. La compañía tiene 486.85 millones de acciones en circulación, y la venta propuesta representa aproximadamente el 0.005% del total de acciones.

Zai Lab의 이사 겸 임원인 Ying Du가 Fidelity Brokerage Services를 통해 총 시장 가치가 $855,196.4723,669 미국예탁증서(ADS) 매각 예정임을 알리는 Form 144를 제출했습니다. 해당 주식은 2025년 6월 25일 제한 주식 권리 행사(vesting)를 통해 보상 차원에서 취득한 것입니다.

Du의 최근 주요 거래 활동은 다음과 같습니다:

  • 2025년 5월에 총 196,389주를 매각하여 총 수익 $5.68백만 달성
  • 2025년 4월에 두 차례 소규모 매각으로 총 8,753주를 매각하여 $305,978 수익

신고서에는 매각이 부분적으로 권리 행사된 주식 보상에 따른 세금 납부를 위한 것임을 명시하고 있습니다. Du는 Zai Lab의 운영과 관련된 미공개 중대한 부정적 정보가 없음을 인증했습니다. 회사의 발행 주식 수는 4억 8,685만 주이며, 이번 매각은 전체 주식의 약 0.005%에 해당합니다.

Ying Du, Directeur et cadre de Zai Lab, a déposé le Formulaire 144 indiquant une proposition de vente de 23 669 American Depositary Shares pour une valeur marchande totale de 855 196,47 $ via Fidelity Brokerage Services. Les actions ont été acquises par l'acquisition de droits sur des actions restreintes le 25 juin 2025, dans le cadre de la rémunération.

Les activités récentes notables de Du incluent :

  • Plusieurs ventes importantes en mai 2025 totalisant 196 389 actions pour un produit combiné de 5,68 millions de $
  • Deux ventes plus petites en avril 2025 totalisant 8 753 actions pour 305 978 $

Le dépôt indique que la vente vise en partie à couvrir des obligations fiscales liées aux attributions d'actions acquises. Du a certifié ne pas avoir connaissance d'informations défavorables importantes non divulguées concernant les opérations de Zai Lab. La société compte 486,85 millions d'actions en circulation, et la vente proposée représente environ 0,005 % du total des actions.

Ying Du, Direktor und leitender Angestellter von Zai Lab, reichte Formular 144 ein, das einen geplanten Verkauf von 23.669 American Depositary Shares mit einem Gesamtmarktwert von 855.196,47 $ über Fidelity Brokerage Services anzeigt. Die Aktien wurden am 25. Juni 2025 durch die Freigabe von beschränkten Aktien im Rahmen der Vergütung erworben.

Bemerkenswerte jüngste Handelsaktivitäten von Du umfassen:

  • Mehrere größere Verkäufe im Mai 2025 mit insgesamt 196.389 Aktien und Erlösen von 5,68 Millionen $
  • Zwei kleinere Verkäufe im April 2025 mit insgesamt 8.753 Aktien für 305.978 $

Die Einreichung gibt an, dass der Verkauf teilweise dazu dient, Steuerverpflichtungen aus gewährten Aktienprämien zu decken. Du hat bestätigt, keine Kenntnis von nicht offengelegten wesentlichen nachteiligen Informationen bezüglich der Geschäfte von Zai Lab zu haben. Das Unternehmen hat 486,85 Millionen Aktien ausstehend, und der geplante Verkauf entspricht etwa 0,005 % der Gesamtaktien.

Positive
  • None.
Negative
  • Director and Officer Ying Du has sold 228,811 shares worth approximately $6.85M over the past 3 months, including a recent planned sale of 23,669 shares ($855K), indicating significant insider selling pressure
  • The pattern of large sequential sales (three 50,000 share blocks in May 2025) suggests systematic reduction of insider holdings

Ying Du, Direttore e Dirigente di Zai Lab, ha presentato il Modulo 144 indicando la proposta vendita di 23.669 American Depositary Shares per un valore di mercato complessivo di 855.196,47 $ tramite Fidelity Brokerage Services. Le azioni sono state acquisite tramite il vesting di azioni vincolate il 25 giugno 2025, come parte della retribuzione.

Tra le attività di trading recenti più rilevanti di Du si segnalano:

  • Numerose vendite importanti a maggio 2025 per un totale di 196.389 azioni con proventi complessivi di 5,68 milioni di $
  • Due vendite minori ad aprile 2025 per un totale di 8.753 azioni per 305.978 $

La dichiarazione indica che la vendita è in parte destinata a coprire obblighi fiscali derivanti da premi azionari maturati. Du ha certificato di non avere conoscenza di informazioni materiali negative non divulgate riguardanti le operazioni di Zai Lab. La società ha 486,85 milioni di azioni in circolazione e la vendita proposta rappresenta circa lo 0,005% del totale azionario.

Ying Du, Director y Oficial de Zai Lab, presentó el Formulario 144 indicando una propuesta de venta de 23,669 American Depositary Shares con un valor de mercado agregado de $855,196.47 a través de Fidelity Brokerage Services. Las acciones fueron adquiridas mediante la consolidación de acciones restringidas el 25 de junio de 2025, como parte de su compensación.

Las actividades comerciales recientes destacadas de Du incluyen:

  • Múltiples ventas grandes en mayo de 2025 que totalizan 196,389 acciones con ingresos combinados de $5.68 millones
  • Dos ventas menores en abril de 2025 que suman 8,753 acciones por $305,978

La presentación indica que la venta es parcialmente para cubrir obligaciones fiscales derivadas de premios de acciones consolidadas. Du ha certificado que no tiene conocimiento de información adversa material no divulgada sobre las operaciones de Zai Lab. La compañía tiene 486.85 millones de acciones en circulación, y la venta propuesta representa aproximadamente el 0.005% del total de acciones.

Zai Lab의 이사 겸 임원인 Ying Du가 Fidelity Brokerage Services를 통해 총 시장 가치가 $855,196.4723,669 미국예탁증서(ADS) 매각 예정임을 알리는 Form 144를 제출했습니다. 해당 주식은 2025년 6월 25일 제한 주식 권리 행사(vesting)를 통해 보상 차원에서 취득한 것입니다.

Du의 최근 주요 거래 활동은 다음과 같습니다:

  • 2025년 5월에 총 196,389주를 매각하여 총 수익 $5.68백만 달성
  • 2025년 4월에 두 차례 소규모 매각으로 총 8,753주를 매각하여 $305,978 수익

신고서에는 매각이 부분적으로 권리 행사된 주식 보상에 따른 세금 납부를 위한 것임을 명시하고 있습니다. Du는 Zai Lab의 운영과 관련된 미공개 중대한 부정적 정보가 없음을 인증했습니다. 회사의 발행 주식 수는 4억 8,685만 주이며, 이번 매각은 전체 주식의 약 0.005%에 해당합니다.

Ying Du, Directeur et cadre de Zai Lab, a déposé le Formulaire 144 indiquant une proposition de vente de 23 669 American Depositary Shares pour une valeur marchande totale de 855 196,47 $ via Fidelity Brokerage Services. Les actions ont été acquises par l'acquisition de droits sur des actions restreintes le 25 juin 2025, dans le cadre de la rémunération.

Les activités récentes notables de Du incluent :

  • Plusieurs ventes importantes en mai 2025 totalisant 196 389 actions pour un produit combiné de 5,68 millions de $
  • Deux ventes plus petites en avril 2025 totalisant 8 753 actions pour 305 978 $

Le dépôt indique que la vente vise en partie à couvrir des obligations fiscales liées aux attributions d'actions acquises. Du a certifié ne pas avoir connaissance d'informations défavorables importantes non divulguées concernant les opérations de Zai Lab. La société compte 486,85 millions d'actions en circulation, et la vente proposée représente environ 0,005 % du total des actions.

Ying Du, Direktor und leitender Angestellter von Zai Lab, reichte Formular 144 ein, das einen geplanten Verkauf von 23.669 American Depositary Shares mit einem Gesamtmarktwert von 855.196,47 $ über Fidelity Brokerage Services anzeigt. Die Aktien wurden am 25. Juni 2025 durch die Freigabe von beschränkten Aktien im Rahmen der Vergütung erworben.

Bemerkenswerte jüngste Handelsaktivitäten von Du umfassen:

  • Mehrere größere Verkäufe im Mai 2025 mit insgesamt 196.389 Aktien und Erlösen von 5,68 Millionen $
  • Zwei kleinere Verkäufe im April 2025 mit insgesamt 8.753 Aktien für 305.978 $

Die Einreichung gibt an, dass der Verkauf teilweise dazu dient, Steuerverpflichtungen aus gewährten Aktienprämien zu decken. Du hat bestätigt, keine Kenntnis von nicht offengelegten wesentlichen nachteiligen Informationen bezüglich der Geschäfte von Zai Lab zu haben. Das Unternehmen hat 486,85 Millionen Aktien ausstehend, und der geplante Verkauf entspricht etwa 0,005 % der Gesamtaktien.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ZLAB shares is insider Ying Du planning to sell according to the Form 144 filed on June 28, 2025?

According to the Form 144 filing, Ying Du plans to sell 23,669 American Depositary Shares of Zai Lab Limited (ZLAB) with an aggregate market value of $855,196.47. The approximate date of sale is indicated as June 26, 2025, and the shares will be sold through Fidelity Brokerage Services LLC on NASDAQ.

How many ZLAB shares has Ying Du sold in the past 3 months before this Form 144 filing?

In the 3 months prior to this filing, Ying Du sold a total of 205,142 American Depositary Shares of ZLAB in multiple transactions: April 2, 2025: 5,808 shares ($208,473.51), April 4, 2025: 2,945 shares ($97,504.53), May 9-14, 2025: 196,389 shares across four transactions totaling approximately $5.68 million.

What is the reason for Ying Du's ZLAB share sale in June 2025?

According to the Form 144's remarks section, the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. The shares being sold were acquired through Restricted Stock Vesting on June 25, 2025, as part of compensation.

What positions does Ying Du hold at ZLAB?

According to the Form 144 filing, Ying Du holds dual positions at Zai Lab Limited (ZLAB), serving as both an Officer and Director of the company.

What is the total number of ZLAB shares outstanding as of June 2025?

According to the Form 144 filing, Zai Lab Limited (ZLAB) has 486,853,250 shares or units outstanding at the time of the filing in June 2025.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

3.77B
106.54M
1.42%
50.94%
3.61%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI